AuthorsㄩAmir T. Fathi; Alexander E. Perl; Geoffrey G. Fell; Brian A. Jonas; Brittany K. Ragon; Alice S. Mims; Uma Borate; Gabriel N. Mannis; Karen Quillen; Maximilian Stahl; Brandon J. Aubrey; Paul Koller; Andrew S. Artz; Monzr M. Al Malki; Anthony S. Stein; Guido Marcucci; Mary Linton B. Peters; Timothy A. Graubert; Peter Westervelt; Philip C. Amrein; Hanno R. Hock; Andrew M. Brunner; Gabriela Hobbs; Rupa Narayan; Michelle H. Lee; Peter G. Miller; Alyssa L. Watson; Richard Hao; Abigail C. Marola; Jennifer Lombardi-Story; Shilton Dhaver; Michael R. Grunwald; Yi-Bin Chen; Matthew J. Weinstock; Andrew H. Matthews; Ian McGovern; Brent L. Wood; Christopher S. Hourigan; Donna S. Neuberg; Areej El-Jawahri; Ibrahim Aldoss
30
Tarlatamab每Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer
